Carlat Psychiatry News | Stimulant Fraud • Oral Ketamine • E-Cigarettes • Benzo Tapering • CBD
💡Subscribe to our newsletter: ➡️Check out our website:
================
Follow Carlat:
🔴SUBSCRIBE ► / @thecarlatreport
➡️Twitter: / CarlatPsych
================
References:
Hines, Lindsey A et al. “Incident psychotic experiences following self-reported use of high-
potency cannabis: Results from a longitudinal cohort study.” Addiction (Abingdon, England) vol.
119,9 (2024): 1629-1634. doi:10.1111/add.16517
Fucito, Lisa M et al. “Varenicline for E-Cigarette Cessation in Adults: A Preliminary Placebo-
Controlled Randomized Trial.” American journal of preventive medicine vol. 67,2 (2024): 296-
298. doi:10.1016/j.amepre.2024.04.007
Glue, Paul et al. “Extended-release ketamine tablets for treatment-resistant depression: a
randomized placebo-controlled phase 2 trial.” Nature medicine vol. 30,7 (2024): 2004-2009.
doi:10.1038/s41591-024-03063-x
Gundugurti, Prasad Rao et al. “Evaluation of the efficacy, safety, and pharmacokinetics of
nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate
anxiety subjects: A double blind multicenter randomized clinical trial.” Asian journal of
psychiatry vol. 97 (2024): 104073. doi:10.1016/j.ajp.2024.104073
Rohde, Christopher et al. “A Nationwide Target Trial Emulation Assessing the Risk of
Antidepressant-Induced Mania Among Patients With Bipolar Depression.” The American
journal of psychiatry vol. 181,7 (2024): 630-638. doi:10.1176/appi.ajp.20230477
Tuisku, Anna et al. “Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A
Randomized Clinical Trial.” JAMA internal medicine vol. 184,8 (2024): 915-921.
doi:10.1001/jamainternmed.2024.1822
Benzodiazapene Tapering Guidelines:
================
0:00 - Intro
0:29 DOJ Charges Telehealth Executives
1:55 Oral Extended Release Ketamine
3:29 MDMA Trials Suspended
04:43 Liquid Clonidine and Liquid Lithium
5:46 Benzodiazepine Tapering Guidelines
8:01 Antidepressants in Bipolar Disorder
10:52 Vaping Trials and Smoking Cessation
12:54 Brexpiprazole & Sertraline For PTSD
14:15 CBD Oil for Anxiety
#MentalHealthNews #psychiatry #psychiatricmedications #psychnews #psychiatrynews #psychopharmacology #pmhnp #psychnp
================
In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials.
Healthcare Fraud Charges: The US DOJ has charged executives at Done, a California telehealth company, for allegedly prescribing 40 million Adderall pills without proper evaluation.
Extended Release Oral Ketamine: New trials on an extended release oral ketamine show potential for treatment-resistant depression. (
MDMA-assisted Psychotherapy Setbacks: After FDA approval was pulled due to ethical concerns, can upcoming trials revive this promising therapy for PTSD?
Liquid Formulations: Onyda is brand name for the new liquid Clonidine XR and the return of liquid lithium citrate offer new options for ADHD and bipolar patients.
Benzodiazepine Tapering Guidelines: The American Society of Addiction Medicine's new draft guidelinesadvocate for a careful, patient-centric approach, especially for vulnerable populations.
Antidepressants and Bipolar Disorder: A Danish study provides some reassurance about using antidepressants in bipolar disorder, but its methodology leaves some questions unanswered.
E-Cigarettes vs. Chantix: A new trial finds nicotine e-cigarettes as effective as Chantix for smoking cessation, but flavored vape products and their health risks continue to spark debate.
Brexpiprazole and Sertraline for PTSD: Brexpiprazole showing promise as an add-on treatment to sertraline, but will the FDA approve this new therapy?
CBD Oil for Anxiety: A new phase 3 trial offers hope for treating anxiety with CBD oil, though its high cost rmay emain a barrier for many patients. #four five cbd gummies #relive cbd gummies #ivermectin cbd gummies #beezbee cbd gummy reviews
Carlat Psychiatry News | Stimulant Fraud • Oral Ketamine • E-Cigarettes • Benzo Tapering • CBD [Gyj_OKkteXy]
Carlat Psychiatry News | Stimulant Fraud • Oral Ketamine • E-Cigarettes • Benzo Tapering • CBD
💡Subscribe to our newsletter: ➡️Check out our website:
================
Follow Carlat:
🔴SUBSCRIBE ► / @thecarlatreport
➡️Twitter: / CarlatPsych
================
References:
Hines, Lindsey A et al. “Incident psychotic experiences following self-reported use of high-
potency cannabis: Results from a longitudinal cohort study.” Addiction (Abingdon, England) vol.
119,9 (2024): 1629-1634. doi:10.1111/add.16517
Fucito, Lisa M et al. “Varenicline for E-Cigarette Cessation in Adults: A Preliminary Placebo-
Controlled Randomized Trial.” American journal of preventive medicine vol. 67,2 (2024): 296-
298. doi:10.1016/j.amepre.2024.04.007
Glue, Paul et al. “Extended-release ketamine tablets for treatment-resistant depression: a
randomized placebo-controlled phase 2 trial.” Nature medicine vol. 30,7 (2024): 2004-2009.
doi:10.1038/s41591-024-03063-x
Gundugurti, Prasad Rao et al. “Evaluation of the efficacy, safety, and pharmacokinetics of
nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate
anxiety subjects: A double blind multicenter randomized clinical trial.” Asian journal of
psychiatry vol. 97 (2024): 104073. doi:10.1016/j.ajp.2024.104073
Rohde, Christopher et al. “A Nationwide Target Trial Emulation Assessing the Risk of
Antidepressant-Induced Mania Among Patients With Bipolar Depression.” The American
journal of psychiatry vol. 181,7 (2024): 630-638. doi:10.1176/appi.ajp.20230477
Tuisku, Anna et al. “Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A
Randomized Clinical Trial.” JAMA internal medicine vol. 184,8 (2024): 915-921.
doi:10.1001/jamainternmed.2024.1822
Benzodiazapene Tapering Guidelines:
================
0:00 - Intro
0:29 DOJ Charges Telehealth Executives
1:55 Oral Extended Release Ketamine
3:29 MDMA Trials Suspended
04:43 Liquid Clonidine and Liquid Lithium
5:46 Benzodiazepine Tapering Guidelines
8:01 Antidepressants in Bipolar Disorder
10:52 Vaping Trials and Smoking Cessation
12:54 Brexpiprazole & Sertraline For PTSD
14:15 CBD Oil for Anxiety
#MentalHealthNews #psychiatry #psychiatricmedications #psychnews #psychiatrynews #psychopharmacology #pmhnp #psychnp
================
In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials.
Healthcare Fraud Charges: The US DOJ has charged executives at Done, a California telehealth company, for allegedly prescribing 40 million Adderall pills without proper evaluation.
Extended Release Oral Ketamine: New trials on an extended release oral ketamine show potential for treatment-resistant depression. (
MDMA-assisted Psychotherapy Setbacks: After FDA approval was pulled due to ethical concerns, can upcoming trials revive this promising therapy for PTSD?
Liquid Formulations: Onyda is brand name for the new liquid Clonidine XR and the return of liquid lithium citrate offer new options for ADHD and bipolar patients.
Benzodiazepine Tapering Guidelines: The American Society of Addiction Medicine's new draft guidelinesadvocate for a careful, patient-centric approach, especially for vulnerable populations.
Antidepressants and Bipolar Disorder: A Danish study provides some reassurance about using antidepressants in bipolar disorder, but its methodology leaves some questions unanswered.
E-Cigarettes vs. Chantix: A new trial finds nicotine e-cigarettes as effective as Chantix for smoking cessation, but flavored vape products and their health risks continue to spark debate.
Brexpiprazole and Sertraline for PTSD: Brexpiprazole showing promise as an add-on treatment to sertraline, but will the FDA approve this new therapy?
CBD Oil for Anxiety: A new phase 3 trial offers hope for treating anxiety with CBD oil, though its high cost rmay emain a barrier for many patients. #four five cbd gummies #relive cbd gummies #ivermectin cbd gummies #beezbee cbd gummy reviews